---
figid: PMC10540689__fphar-14-1247800-g007
pmcid: PMC10540689
image_filename: fphar-14-1247800-g007.jpg
figure_link: /pmc/articles/PMC10540689/figure/F7/
number: FIGURE 7
figure_title: ''
caption: 'Tan inhibited the PI3K/Akt signaling pathway in pulmonary fibrosis. (A)
  Western blotting of p-PI3K, PI3K, p-Akt, and Akt proteins in mice lung. (B) Quantification
  of the p-PI3K/PI3K ratio. (C) p-Akt/Akt ratio. (D) Western blotting of p-PI3K, PI3K,
  p-Akt, and Akt proteins in TGF-Î²1-stimulated A549 cells. (E) p-PI3K/PI3K ratio.
  (F) p-Akt/Akt ratio. ##p < 0.01, compared with the control group. *p < 0.05, **p
  < 0.01, compared with the model group.'
article_title: Tangeretin attenuates bleomycin-induced pulmonary fibrosis by inhibiting
  epithelial-mesenchymal transition via the PI3K/Akt pathway.
citation: Jiang Li, et al. Front Pharmacol. 2023;14:1247800.
year: '2023'

doi: 10.3389/fphar.2023.1247800
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.

keywords:
- pulmonary fibrosis
- tangeretin
- PI3K/Akt signaling pathway
- epithelial-mesenchymal transition
- bleomycin

---
